Today: 19 March 2026
Subscribe
Browse Category

NYSE:CTLT 27 June 2025

Top Biotechnology and Health Tech Trends in 2025: Mid-Year Update and Forecast (Updated: June 27th, 2025)

Top Biotechnology and Health Tech Trends in 2025: Mid-Year Update and Forecast (Updated: June 27th, 2025)

The FDA approved Abeona’s Zevaskyn, the first cell-based gene therapy for RDEB, in April 2025, with launch set for Q3 at $3.1 million. Vertex’s CRISPR therapy Casgevy generated $2 million in Q3 2024. Novo Holdings acquired Catalent for $16.5 billion in January 2025 to secure GLP-1 drug manufacturing. Johnson & Johnson bought Intra-Cellular Therapies for $14.6 billion, expanding its neuroscience portfolio.
27 June 2025
···········

Stock Market Today

  • Sensex Drops 2,500 Points Amid Rising Crude Prices and Geopolitical Tensions
    March 19, 2026, 4:54 PM EDT. India's Sensex plunged over 2,490 points (3.26%), settling at 74,207 amid a surge in crude oil prices and escalating geopolitical tensions between the US, Israel, and Iran. The Nifty also slipped 775 points to 23,002. Rising crude prices-Brent crude rose 3.77% to $111.4 per barrel-fueled fears of inflation and supply disruptions, exacerbated by Iran's attacks on Gulf energy infrastructure. Major index losers included HDFC Bank and Shriram Finance, while Oil and Natural Gas Corporation (ONGC) and Reliance Industries gained. Foreign institutional investors continued selling pressure. Meanwhile, silver and gold prices tumbled sharply, with silver down 7% and gold by 4.37%, pressured by global selloffs. Market sentiment remains fragile amid heightened uncertainty and inflation fears impacting global and Indian financial markets.
Go toTop